Practice Guideline
doi: 10.1016/j.jhep.2018.03.026.
Epub 2018 Apr 9.
EASL Recommendations on Treatment of Hepatitis C 2018
Collaborators
- PMID: 29650333
- DOI: 10.1016/j.jhep.2018.03.026
Item in Clipboard
Practice Guideline
EASL Recommendations on Treatment of Hepatitis C 2018
J Hepatol.
2018 Aug.
No abstract available
Comment in
-
Reply to: "Sofosbuvir/velpatasvir for patients with chronic genotype 3 HCV infection with compensated cirrhosis: Response to EASL recommendations on treatment of Hepatitis C 2018": EASL Recommendations on Treatment of Hepatitis C 2018: Precision on the treatment of patients with genotype 3a infection and compensated cirrhosis.J Hepatol. 2019 Mar;70(3):562-564. doi: 10.1016/j.jhep.2018.11.004. Epub 2018 Nov 13. J Hepatol. 2019. PMID: 30439391 No abstract available.
-
Sofosbuvir/velpatasvir for patients with chronic genotype 3 HCV infection with compensated cirrhosis: Response to EASL Recommendations on Treatment of Hepatitis C 2018.J Hepatol. 2019 Mar;70(3):561-562. doi: 10.1016/j.jhep.2018.08.029. Epub 2018 Nov 13. J Hepatol. 2019. PMID: 30445102 No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
